Cargando…

Strategy to address innovative off-label medication use in China: grading management

Detalles Bibliográficos
Autores principales: Wu, Hanbin, Wu, Gao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158171/
https://www.ncbi.nlm.nih.gov/pubmed/25128075
http://dx.doi.org/10.1007/s00228-014-1729-3
_version_ 1782334003757449216
author Wu, Hanbin
Wu, Gao
author_facet Wu, Hanbin
Wu, Gao
author_sort Wu, Hanbin
collection PubMed
description
format Online
Article
Text
id pubmed-4158171
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-41581712014-09-10 Strategy to address innovative off-label medication use in China: grading management Wu, Hanbin Wu, Gao Eur J Clin Pharmacol Letter to the Editors Springer Berlin Heidelberg 2014-08-17 2014 /pmc/articles/PMC4158171/ /pubmed/25128075 http://dx.doi.org/10.1007/s00228-014-1729-3 Text en © The Author(s) 2014 https://creativecommons.org/licenses/by/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
spellingShingle Letter to the Editors
Wu, Hanbin
Wu, Gao
Strategy to address innovative off-label medication use in China: grading management
title Strategy to address innovative off-label medication use in China: grading management
title_full Strategy to address innovative off-label medication use in China: grading management
title_fullStr Strategy to address innovative off-label medication use in China: grading management
title_full_unstemmed Strategy to address innovative off-label medication use in China: grading management
title_short Strategy to address innovative off-label medication use in China: grading management
title_sort strategy to address innovative off-label medication use in china: grading management
topic Letter to the Editors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158171/
https://www.ncbi.nlm.nih.gov/pubmed/25128075
http://dx.doi.org/10.1007/s00228-014-1729-3
work_keys_str_mv AT wuhanbin strategytoaddressinnovativeofflabelmedicationuseinchinagradingmanagement
AT wugao strategytoaddressinnovativeofflabelmedicationuseinchinagradingmanagement